Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith

Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith

US Patent 10137135 · Granted Nov 27, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sirtuin modulating compounds and applications thereof2025
Sirtuin modulating compounds and applications thereof2024
Formulations and methods for providing progestin-only contraception while minimi2019
Formulations and methods for providing progestin-only contraception while minimi2019
Formulations and methods for providing progestin-only contraception while minimi2019
Formulations and methods for providing progestin-only contraception while minimi2019
Compositions and methods for unoccluded transdermal oxybutynin therapy2019
Phenazopyridine compounds2012
Unoccluded topical oxybutynin gel composition and methods for transdermal oxybut2012
Phenazopyridine compounds2011
Compositions and methods for transdermal oxybutynin therapy2007
Compositions and methods for minimizing adverse drug experiences associated with2006